Cell Growth & Differentiation, Vol 1, Issue 4 191-200, Copyright © 1990 by American Association of Cancer Research

ARTICLES

Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity

CY Hsu, M Mohammadi, M Nathan, A Honegger, A Ullrich, J Schlessinger and DR Hurwitz
Rorer Biotechnology, Inc., King of Prussia, Pennsylvania 19406.

We have generated a recombinant baculovirus using the high expression vector pVL941 containing the complementary DNA encoding the intracellular domain of the human epidermal growth factor receptor (EGFR-IC). Upon infection of Spodoptera frugiperda insect cells, protein tyrosine kinase-active EGFR-IC was produced. The expressed protein has a molecular weight of 61,000 and is specifically recognized by antibodies directed against peptides representing different regions of human EGFR-IC. Upon sonication of infected cells, EGFR-IC was detected in both the soluble and insoluble fractions of the cell lysate. About 20-50% of the expressed EGFR-IC was soluble. Metabolic labeling and protein analyses showed that EGFR-IC comprised 7% of newly synthesized proteins in the cytoplasmic lysate and 0.1-0.2% of the total soluble protein. We have used a three-step purification procedure (fast-Q-Sepharose and phenyl-Sepharose column chromatographies and 30% ammonium sulfate precipitation) to purify EGFR-IC to 85% purity with 15-20% recovery from the initial soluble lysate. A yield of 3-4 mg of purified EGFR-IC has been consistently produced from 20 roller bottles with 2-4 x 10(8) infected cells/bottle. The tyrosine kinase activity was retained through purification. The enzyme demonstrated much higher autophosphorylation activity in the presence of Mn2+ than Mg2+. Phosphopeptide mapping revealed the same autophosphorylation sites utilized by EGFR-IC as those identified in wild-type EGFR. EGFR-IC-catalyzed phosphorylation of either a synthetic peptide representing the major autophosphorylation site or angiotensin II showed that the baculovirus-expressed EGFR-IC exhibits similar enzymatic kinetic characteristics to the intact activated EGFR kinase.

This article has been cited by other articles:

				B. Metge, S. Ofori-Acquah, T. Stevens, and R. Balczon Stat3 Activity Is Required for Centrosome Duplication in Chinese Hamster Ovary Cells J. Biol. Chem., October 1, 2004; 279(40): 41801 - 41806. [Abstract] [Full Text] [PDF]

				E. A. Miljan, E. J. Meuillet, B. Mania-Farnell, D. George, H. Yamamoto, H.-G. Simon, and E. G. Bremer Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides J. Biol. Chem., March 15, 2002; 277(12): 10108 - 10113. [Abstract] [Full Text] [PDF]

				N. Ito, C. Wernstedt, U. Engstrom, and L. Claesson-Welsh Identification of Vascular Endothelial Growth Factor Receptor-1 Tyrosine Phosphorylation Sites and Binding of SH2 Domain-containing Molecules J. Biol. Chem., September 4, 1998; 273(36): 23410 - 23418. [Abstract] [Full Text] [PDF]

				P. Goldschmidt-Clermont, J. Kim, L. Machesky, S. Rhee, and T. Pollard Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation Science, March 8, 1991; 251(4998): 1231 - 1233. [Abstract] [PDF]

				P. S. Brignola, K. Lackey, S. H. Kadwell, C. Hoffman, E. Horne, H. L. Carter, J. D. Stuart, K. Blackburn, M. B. Moyer, K. J. Alligood, et al. Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains. DEMONSTRATION OF DIFFERENTIAL SENSITIVITY TO KINASE INHIBITORS J. Biol. Chem., January 4, 2002; 277(2): 1576 - 1585. [Abstract] [Full Text] [PDF]